Neutrophil extracellular traps aggravate neutrophil reverse transendothelial migration during traumatic brain injury

Ruitian Zhou1, Tong Zhang2, Jianbin Sun2

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Army Medical University, Chongqing, 400038, China; Battalion 5, Brigade 2 of Medical Undergraduate, School of Basic Medicine, Army Medical University, Chongqing, 400038, China.

Insights

Neutrophil reverse trans-endothelial migration (rTEM) in traumatic brain injury (TBI) is promoted by neutrophil extracellular traps (NETs). Inhibiting NETs reduces rTEM, aiding neurological recovery after TBI.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • Neutrophils migrate from blood vessels into tissues to fight infection.
  • Reverse trans-endothelial migration (rTEM) allows neutrophils to return to circulation, potentially spreading inflammation.
  • Mechanisms of rTEM, especially after mechanical injury like traumatic brain injury (TBI), are not well understood.

Purpose of the Study:

  • To investigate the mechanisms regulating neutrophil rTEM in a murine TBI model.
  • To identify factors promoting neutrophil rTEM following TBI.
  • To evaluate the therapeutic potential of targeting rTEM for TBI recovery.

Main Methods:

  • Established a murine mechanical injury model of TBI.
  • Utilized in vivo LY6G-Biotin/Streptavidin (STREPT) crosslinking for neutrophil labeling.
  • Employed endothelial/neutrophil Double-Transwell assays for in vitro simulation.
  • Assessed expression of ICAM-1 and JAM-C.
  • Administered NETs inhibitor Cl-Amidine in vivo.

Main Results:

  • Observed neutrophil rTEM in the acute phase of TBI, with neutrophils migrating to tibial bone marrow.
  • Found high ICAM-1 expression on migrating neutrophils, correlated with NETs levels in brain tissue.
  • Demonstrated that NETs reduce endothelial JAM-C and increase neutrophil ICAM-1 expression in vitro.
  • Cl-Amidine treatment reduced neutrophil rTEM and improved neurological recovery and inflammation resolution post-TBI.

Conclusions:

  • NETs promote neutrophil rTEM in TBI by degrading endothelial JAM-C and upregulating neutrophil ICAM-1.
  • rTEM contributes to neutrophil distribution in peripheral organs after TBI.
  • Targeting NETs-mediated rTEM is a promising therapeutic strategy for TBI.